<?xml version="1.0" encoding="UTF-8"?>
<ref id="B7">
 <label>7</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Eefting</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Halkes</surname>
    <given-names>CJ</given-names>
   </name>
   <name>
    <surname>de Wreede</surname>
    <given-names>LC</given-names>
   </name>
   <name>
    <surname>van Pelt</surname>
    <given-names>CM</given-names>
   </name>
   <name>
    <surname>Kersting</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Marijt</surname>
    <given-names>EW</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Myeloablative T cell-depleted alloSCT with early sequential prophylactic donor lymphocyte infusion is an efficient and safe post-remission treatment for adult ALL</article-title>. 
  <source>Bone Marrow Transplant</source> (
  <year>2014</year>) 
  <volume>49</volume>(
  <issue>2</issue>):
  <fpage>287</fpage>â€“
  <lpage>91</lpage>.
  <pub-id pub-id-type="doi">10.1038/bmt.2013.111</pub-id>
  <?supplied-pmid 23933760?>
  <pub-id pub-id-type="pmid">23933760</pub-id>
 </mixed-citation>
</ref>
